Patients with coronavirus disease 2019 (COVID-19) often exhibit diverse disease
progressions associated with various infectious ability, symptoms, and clinical treatments. To …

Critical illness, such as severe COVID-19, is heterogenous in presentation and treatment
response. However, it remains possible that clinical course may be influenced by dynamic …

Background: COVID-19 is a global pandemic leading to high death tolls worldwide day by
day. Clinical evidence suggests that COVID-19 patients can be classified as non-severe …

Understanding the underlying mechanisms of COVID-19 progression and the impact of
various pharmaceutical interventions is crucial for the clinical management of the disease …

SARS-CoV-2 infection results in highly heterogeneous outcomes, from cure without
symptoms to acute respiratory distress and death. Empirical evidence points to the …

The disease caused by SARS-CoV-2 is a global pandemic that threatens to bring long-term
changes worldwide. Approximately 80% of infected patients are asymptomatic or have mild …

Once challenged by the SARS-CoV-2 virus, the human host immune system triggers a
dynamic process against infection. We constructed a mathematical model to describe host …

The disease caused by SARS-CoV-2—CoVID-19—is a global pandemic that has brought
severe changes worldwide. Approximately 80% of the infected patients are largely …

Background Immune system conditions of the patient is a key factor in COVID-19 infection
survival. A growing number of studies have focused on immunological determinants to …

The scientific community is focused on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …